Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted cardiometabolic therapeutics to improve outcomes for patients struggling with type 2 diabetes and related metabolic conditions
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted cardiometabolic therapeutics to improve outcomes for patients struggling with type 2 diabetes and related metabolic conditions.
The top three firms on F4's Biotech & Life Sciences investor list.